The Ministry of Industry and Trade intends to extend the "second wheel" rule to all medical devices.

Deputy Minister of Industry and Trade of the Russian Federation Ekaterina Priezzheva spoke about the idea of ​​expanding the rule to all medical devices at the annual NOVAMED-2025 forum. "At the recent coordination council meeting, we proposed to supervisor Tatyana Alekseyevna Golikova that we expand this support mechanism to all medical devices. Our colleagues from the Ministry of Health and Roszdravnadzor conceptually supported our initiative. And, in principle, Tatyana Alekseyevna also supported the concept. We have been instructed to work with colleagues to examine further whether there are any risks in implementing this approach," Priezzheva said.

According to her, the Ministry of Industry and Trade believes it's crucial to shift from the targeted inclusion of various types of medical devices in this support mechanism to a broad approach, which is already being implemented in the pharmaceutical industry. "It's proven effective. Therefore, we believe that exactly the same practice can be applied to medical devices," Priezzheva emphasized. "If we succeed in implementing this approach for medical devices with a 'second wheel,' I believe it will be a very significant incentive for our manufacturers."

The "second wheel" system imposes protectionist measures on domestic products in public procurement: if even one bid for a product from the EAEU appears in a tender, all bids for imported products are automatically rejected.

In August 2021, the Russian government introduced a "second-odds-to-be-redundant" rule for public procurement of 30 types of medical equipment, including CT and MRI scanners, ultrasound machines, defibrillators, air purifiers, and neonatal equipment. Since then, the list has been expanded several times . As of November 2025, the "second-odds-to-be-redundant" rule applies to 110 types of medical devices.

In December 2024, the government, by Resolution No. 1875, extended the "second-odds-to-be-used" rule to public procurement of drugs from the VED and SZLS lists. Effective January 1, 2025, this mechanism began to apply to foreign drugs whose production is not localized in Russia, and from September 1, to local manufacturers of active pharmaceutical ingredients.